Publication date: May 2026Source: Journal of Ginseng Research, Volume 50, Issue 3Author(s): Zheng-Wei Liang, Shi-Cheng Tang, Yan Ma, Teng Wang, Zheng Lv, Yan-Hui Guan, Jun-Wen Chen, Ming Zhao, Sheng-Chao Yang
Publication date: March 2026Source: Journal of Ginseng Research, Volume 50, Issue 2Author(s): Jeongeui Hong, Wonsil Bae, Jung-Woo Lee, Jang-Uk Kim, Kyung Ho Ma, Donghwan Shim, Hojin Ryu
Publication date: March 2026Source: Journal of Ginseng Research, Volume 50, Issue 2Author(s): Shou-rong Wu, Shuo Yuan, Yi-fan Li, Xiang-yang Liu, Peng-fei Tu, Xiao-yu Guo, Yong Jiang
Publication date: March 2026Source: Journal of Ginseng Research, Volume 50, Issue 2Author(s): Zheng-Wei Liang, Yan-Hui Guan, Zheng Lv, Sheng-Chao Yang, Ming Zhao, Jun-Wen Chen
Publication date: Available online 23 February 2026Source: Journal of Ginseng ResearchAuthor(s): Sang-Hoon Lee, Jae-Hee Kwon, Hyun-Woo Kim, Se Hwan Mun, Young Yang, Jihoon Kim, Kwang-Won Seo, Do-Kyun Kim, Young-Eun Cho
Publication date: Available online 28 February 2026Source: Journal of Ginseng ResearchAuthor(s): Sung Ha Lim, Hee-Seok Seo, Hyun Kang, Seung-Phil Hong
Publication date: Available online 24 February 2026Source: Journal of Ginseng ResearchAuthor(s): Meng Sun, Ying Liu, Meng-yang Wang, Wei Liu
This article aims to compare and analyze the contents of ginsenosides in ginseng with different plant ages from different localities in China.
Panax ginseng, also called Asian or Korean ginseng, has long been traditionally used in Korea and China to treat various diseases. The major active ingredients of Panax ginseng are ginsenosides, which have been shown to have a variety of therapeutic effects, including anti-oxidation, anti-inflammatory, vasorelaxation, antiallergic, anti-diabetic, and anti-cancer. To date, approximately 40 ginsenoside components have been reported. Current research is concentrating on using a single ginseng compound, one of the ginsenosides, instead of the total ginseng compounds, to determine the mechanisms of ginseng and ginsenosides.
Notoginseng stem-leaf ginsenosides did not be well used. To improve the utilization, the biotransformation of notoginseng stem-leaf ginsenosides was studied using ginsenosidase type-I from Aspergillus niger g.848.
